COF
62
3
RRC
52
-6
TXN
43
-5
GME
66
-5
CI
45
-3
DGX
48
11
AON
54
2
DRI
50
-3
R
70
-3
NEM
40
3
CMI
64
-3
MSFT
46
-11
PLD
45
-5
WBA
43
-4
ECL
55
-2
FITB
60
-5
ORLY
60
-5
FAST
57
-3
STZ
52
-6
NVDA
52
-5
COF
62
3
RRC
52
-6
TXN
43
-5
GME
66
-5
CI
45
-3
DGX
48
11
AON
54
2
DRI
50
-3
R
70
-3
NEM
40
3
CMI
64
-3
MSFT
46
-11
PLD
45
-5
WBA
43
-4
ECL
55
-2
FITB
60
-5
ORLY
60
-5
FAST
57
-3
STZ
52
-6
NVDA
52
-5
Financhill
Back

Dassault Systemes SE Vs. Halozyme Therapeutics Industry Stock Comparison

Sell
50

DASTY
Dassault Systemes SE

Last Price:
32.95
Seasonality Move:
7.37%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Sell
50
Dassault Systemes SE (DASTY) is a Sell

Is Dassault Systemes SE a Buy, Sell or Hold?

  • The current Dassault Systemes SE [DASTY] share price is $32.95. The Score for DASTY is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
  • DASTY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

DASTY Stock Price Chart

What is Dassault Systemes SE's stock price today?

  • The Dassault Systemes SE share price today is $32.95
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DASTY is experiencing slight selling pressure.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

DASTY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.87 Sell
Relative Strength Index (14 RSI): 33.38 Sell
Chaikin Money Flow: -89487 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (33.87 - 35.93) Sell
Bollinger Bands (100): (35.47 - 39.01) Sell

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

DASTY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 34.3 Sell
20-day SMA: 34.55 Sell
50-day SMA: 37.02 Sell
200-day SMA: 40.05 Sell
8-day EMA: 34.01 Sell
20-day EMA: 34.77 Sell
50-day EMA: 36.15 Sell
200-day EMA: 39.1 Sell

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

Dassault Systemes SE Earnings Growth & DASTY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.05 per share, and an increase next year of $0.15 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.35 per share, and an increase next year of $0.56 per share.

Dassault Systemes SE Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):